AI assistant
Sending…
HALLIBURTON CO — Director's Dealing 2020
Jan 3, 2020
30269_dirs_2020-01-03_39ed8ae0-6113-4fbb-90e8-ee2ada5436e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HALLIBURTON CO (HAL)
CIK: 0000045012
Period of Report: 2020-01-01
Reporting Person: Jones Myrtle L (Senior Vice Pres - Tax)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-01 | Common Stock | A | 40866 | $24.47 | Disposed | 69987.673 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy Common Stock | $31.44 | 2028-12-05 | Common Stock (8700) | 8700 | Direct |
| Option to Buy Common Stock | $43.38 | 2027-12-06 | Common Stock (5800) | 5800 | Direct |
| Option to Buy Common Stock | $53.54 | 2026-12-07 | Common Stock (5100) | 5100 | Direct |
| Option to Buy Common Stock | $38.95 | 2025-12-02 | Common Stock (8400) | 8400 | Direct |
| Option to Buy Common Stock | $40.75 | 2024-12-03 | Common Stock (8400) | 8400 | Direct |
| Option to Buy Common Stock | $50.62 | 2023-12-04 | Common Stock (5700) | 5700 | Direct |
| Option to Buy Common Stock | $39.96 | 2023-03-04 | Common Stock (6500) | 6500 | Direct |
Footnotes
F1: Shares awarded pursuant to the Halliburton Company Stock and Incentive Plan. Said Plan provides for the surrender of common stock to the Issuer to satisfy withholding tax obligations.
F2: The January 1, 2020 grant date was on a non-market date. The closing price of Halliburton Company's Common Stock on the New York Stock Exchange on December 31, 2019 was $24.47.
More from HALLIBURTON CO
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 30
Regulatory Filings
2026
Mar 27